Juan Jesús
Gómez-Reino Carnota
Universidade de Santiago de Compostela
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (137)
2018
-
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
Clinical Microbiology and Infection, Vol. 24, pp. S10-S20
2017
-
Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient
Journal of Orthopaedic Research, Vol. 35, Núm. 6, pp. 1299-1303
-
Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients
PLoS ONE, Vol. 12, Núm. 7
-
Five-year Efficacy and safety of tocilizumab monotherapy in patients with rheumatoid arthritis who were methotrexate-And biologic-naive or free of methotrexate for 6 months: The ambition study
Journal of Rheumatology, Vol. 44, Núm. 2, pp. 142-146
-
Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis
Clinical Rheumatology, Vol. 36, Núm. 5, pp. 1167-1172
-
Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis
Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 2, pp. 149-156
2016
-
Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies
PLoS ONE, Vol. 11, Núm. 8
-
Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search update
Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 16-22
-
Independent candidate serum protein biomarkers of response to adalimumab and to infliximab in rheumatoid arthritis: An exploratory study
PLoS ONE, Vol. 11, Núm. 4
-
Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: A systematic review and meta-analysis of drug registries and health care databases
Rheumatology (United Kingdom), Vol. 55, Núm. 3, pp. 523-534
-
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140
2015
-
Apremilast for the treatment of psoriatic arthritis
Expert Review of Clinical Immunology, Vol. 11, Núm. 12, pp. 1281-1290
-
Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate
Arthritis Research and Therapy, Vol. 17, Núm. 1
-
Basic Aspects of Adipokines in Bone Metabolism
Clinical Reviews in Bone and Mineral Metabolism, Vol. 13, Núm. 1, pp. 11-19
-
Choosing the right chondrocyte cell line: Focus on nitric oxide
Journal of Orthopaedic Research, Vol. 33, Núm. 12, pp. 1784-1788
-
Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice
Journal of Bone and Mineral Metabolism, Vol. 33, Núm. 4, pp. 383-391
-
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors
Pharmacogenomics, Vol. 16, Núm. 4, pp. 333-345
-
High sodium intake is associated with self-reported rheumatoid arthritis: A cross sectional and case control analysis within the SUN cohort
Medicine (United States), Vol. 94, Núm. 37
-
IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes
Scientific Reports, Vol. 5
-
Identification of novel adipokines in the joint.Differential expression in healthy and osteoarthritis tissues
PLoS ONE, Vol. 10, Núm. 4